Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triamcinolone injection in frontal sinus surgery
IRCT20211218053446N1Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of triamcinolone in chronic rhinosinusitis (CRS), sponsored by Tabriz University of Medical Sciences. Started Jan 2022; status: completed.
02
Drugs
triamcinolone
03
Conditions
chronic rhinosinusitis (CRS)
Beyond the preview
Go deeper on IRCT20211218053446N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211218053446N1.